![Michelle Mellion](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Mellion
No open positions remaining
Profile
Michelle L.
Mellion formerly worked at Vertex Pharmaceuticals, Inc., as Medical Director from 2016 to 2018, Biogen, Inc., as Associate Medical Director from 2015 to 2016, Fulcrum Therapeutics, Inc., as Executive Medical Director from 2018 to 2022, and PepGen Inc., as Chief Medical Officer from 2024 to 2025.
Dr. Mellion received her doctorate degree from Wake Forest University and undergraduate degree from Colgate University.
Former positions of Michelle Mellion
| Companies | Position | End |
|---|---|---|
| PEPGEN INC. | Chief Tech/Sci/R&D Officer | 03/04/2025 |
| FULCRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 28/02/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 31/07/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 31/10/2016 |
Training of Michelle Mellion
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
- Stock Market
- Insiders
- Michelle Mellion
